Hannah Small, PA
Physician Assistant · Bismarck, NDNPI 1346847670
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,175 of the $10,321 with a category attached, or 69.5%. 38 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 51.4% of the total. Among physician assistant clinicians in ND with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 379 payments — averaging $27.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$5K
- AstraZeneca$806
- GSK$620
- Harmony Biosciences LLC$349
- Boehringer Ingelheim$339
- Merck$232
- plus $3K from 32 others
What the payments were for
- Travel & lodging$3,04630%
- Food & beverage$7,17570%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 94 | $5,304 |
| AstraZeneca | 22 | $806 |
| GSK | 66 | $620 |
| Harmony Biosciences LLC | 14 | $349 |
| Boehringer Ingelheim | 19 | $339 |
| Merck | 12 | $232 |
| Baxter Healthcare | 11 | $221 |
| Melinta Therapeutics, LLC | 12 | $217 |
| Johnson & Johnson(2 entities) | 15 | $211 |
| AbbVie | 10 | $189 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $186 |
| Sanofi | 10 | $173 |
| Regeneron Healthcare Solutions, Inc. | 8 | $152 |
| United Therapeutics Corporation | 8 | $136 |
| Mallinckrodt Hospital Products Inc. | 6 | $114 |
| Pfizer | 6 | $113 |
| Grifols USA, LLC | 7 | $113 |
| Actelion Pharmaceuticals US, Inc. | 2 | $88 |
| Intercept Pharmaceuticals, Inc. | 5 | $80 |
| Mylan Specialty L.p. | 4 | $76 |
| Amgen | 4 | $66 |
| Daiichi Sankyo Inc. | 4 | $63 |
| Ardelyx, Inc. | 4 | $57 |
| QOL Medical, LLC | 3 | $57 |
| Lilly USA, LLC | 3 | $54 |
| La Jolla Pharmaceutical Company | 2 | $39 |
| Advanced Respiratory, Inc | 2 | $35 |
| Aimmune Therapeutics, Inc. | 2 | $34 |
| Insmed, Inc. | 2 | $33 |
| Phadia US Inc. | 2 | $32 |
| Pharmacosmos Therapeutics Inc. | 2 | $31 |
| Vertex | 1 | $20 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $15 |
| Pharming Healthcare, Inc. | 1 | $14 |
| Bristol Myers Squibb | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,321 in reported general payments places this provider in the 95th percentile of 355 physician assistant providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 178 | $157,084 |
| Spiriva RespimatTiotropium Bromide | 120 | $111,138 |
| Breo ElliptaFluticasone/Vilanterol | 141 | $71,949 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 95 | $69,691 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 36 | $26,145 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 37 | $21,495 |
| Incruse ElliptaUmeclidinium Bromide | 41 | $20,777 |
| YupelriRevefenacin | 12 | $17,569 |
| SymbicortBudesonide/Formoterol Fumarate | 40 | $13,717 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 54 | $11,057 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 226 | $9,658 |
| Advair HfaFluticasone Propion/Salmeterol | 24 | $9,232 |
| Arformoterol Tartrate | 17 | $8,051 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 13 | $7,006 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 23 | $4,608 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta | $620 | $275,955396 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat | $339 | $132,633157 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere | $806 | $90,415148 claims |
| Mylan Specialty L.p.Yupelri | $76 | $17,56912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 355 physician assistant providers in North Dakota.
Other physician assistant in Bismarck
- Micheal HenkeBismarck$6K
- Sommer WamsleyBismarck$5K
- Burton MollmanBismarck$5K
- Brooke ArndorferBismarck$5K
- Tara Curtis HaberlockBismarck$4K
- Steele TescherBismarck$4K
- Kari ThomasBismarck$3K
- Allison TaylorBismarck$3K
- Kelsie TescherBismarck$3K
- Kari DatzBismarck$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.